Scientific assessments of creatine are favourable for certain sporting goals, much more cautious about memory, and insufficient to decide for you if you have kidney problems or take medication. So the first question is not “which supplement should I buy?” but “what specific result has been demonstrated in people like me?”
If you search for “creatine medical advice”, you may find a doctor’s testimonial, a precautions sheet or an advert citing a study. These do not all answer the same question. Here is an evidence review to help you prepare a decision, without a pretend consultation or invented medical endorsement.
Creatine: verdict by goal and profile
The following matrix distinguishes between expected benefit, strength of evidence and the need for a prior consultation. The levels are an editorial assessment of the evidence for the stated use, not a rating of your health.
| Goal and population | What the evidence suggests you can expect | Strength of evidence for this goal | Prior consultation |
|---|---|---|---|
| Healthy adult, strength training or brief repeated efforts | Possible improvement in strength and the ability to repeat efforts, with individual variation | Strong for this type of effort | Seek advice if you have a relevant medical history, symptoms or take medication |
| Older adult doing strength training | Possible additional benefit for strength and lean mass compared with training alone | Favourable evidence, dependent on the programme and individual profile | Preferable in cases of frailty, illness or multiple medications |
| Adult aiming only to improve memory or concentration | A reliable general benefit has not been established, despite signals in some studies | Uncertain and debated | Persistent cognitive complaints warrant assessment |
| Athlete focused solely on continuous endurance | Less convincing benefits than for repeated intense efforts | Limited for this goal | Depends on health context and activity |
| Person with kidney disease or abnormal kidney test results | Results in healthy adults cannot determine the decision | Insufficient for self-directed supplementation | Yes, before taking any |
| Pregnancy, breastfeeding or underage individuals | Conclusions for healthy athletic adults cannot be transferred | Insufficient for self-directed use | Do not start without professional assessment |
This assessment draws on the NIH’s institutional overview of performance, the EFSA assessment of cognition and the kidney studies discussed below. The word “creatine” does not come with a single verdict.
Doctors’ opinions, trials and claims: three different levels
A clinical opinion considers an individual: medical history, medications, goals and any tests. A public interview with a doctor may help explain things, but it does not perform that assessment for every reader.
A clinical trial compares groups according to a protocol. It can show an average benefit without guaranteeing that you will respond in the same way. Exclusion criteria matter: a result in selected volunteers does not become blanket approval for patients with illnesses.
A regulated claim defines what a product can claim within a specific framework. It is neither an individual prescription nor validation of every promise surrounding the product. For brief, intense, repeated effort, the European framework notably specifies a daily intake of 3 g for the adults concerned. The 2024 EFSA opinion recalls this sporting context while assessing cognition separately.
A bottle can therefore highlight genuine sports evidence while suggesting a mental benefit that lacks the same support. The mechanism is real; the marketing leap still needs proving.
Why an energy mechanism is not enough
Phosphocreatine helps regenerate ATP quickly, a molecule used to supply cells with energy. This explains its relevance to short, intense muscular efforts. This does not mean creatine creates unlimited energy, replaces training or addresses every cause of fatigue.
The brain also uses the creatine–phosphocreatine system. But a biological role in an organ does not establish that adding more improves performance in someone who is not deficient. This is “Mitochondria Marketing”: invoking a genuine energy mechanism to sell a human benefit that has not yet been demonstrated in the intended context.
Before jumping from muscle to memory, you need trials that measure memory. Before talking about disease prevention, you need clinical results for that disease. A laboratory test and independence maintained for years are two different outcomes.
Sport, ageing and cognition: what we can conclude
Sport: a targeted use, not a prerequisite for every activity
The NIH reports favourable results for intermittent intense efforts and adaptations to structured training. Responses vary between individuals. This overview does not support comparable benefits across all endurance disciplines.
The useful question is therefore concrete: does your programme actually involve efforts to which these results apply? If your goal is simply to move more, establishing a regular routine already gives you a clear priority. Buying the supplement before you have a programme is choosing the accessory before knowing what you will use it for.
Ageing: distinguishing training from independence
The meta-analysis by Chilibeck and colleagues examines creatine combined with resistance training in older adults. Its favourable findings on strength and lean mass do not demonstrate that supplementation alone prevents dependency or falls.
An increase in lean mass is not exactly the same as newly built contractile muscle: this measurement includes water. For someone who is frail, the decision should therefore consider a feasible programme, tolerability and coexisting illnesses, rather than a general “anti-ageing” promise.
Cognition: a disagreement that needs to be made clear
The meta-analysis by Xu and colleagues published in 2024 reports some favourable findings, particularly for memory. It does not find a significant improvement in overall cognition. Populations, tests and protocols differ.
Crucially, EFSA explicitly criticises this review: several related tests from the same participants were pooled as though they were independent. This method inflates participant numbers in the analysis. The agency considers that no conclusion can be drawn from it to substantiate the claim assessed, and does not consider a causal relationship between creatine and improved cognitive function to be established.
This is not proof that no cognitive effect will ever exist. It is a reason not to present memory as an indication as well supported as muscular performance. Persistent mental fatigue or declining memory warrants assessment, rather than an escalating stack of supplements.
When should you seek advice before supplementation?
Kidneys: reassuring in some adults does not mean universally safe
The kidney-focused systematic review published in 2025 finds a small increase in creatinine without a significant decrease in glomerular filtration rate in the pooled data. Creatinine is a marker used to estimate filtration, not filtration itself.
These findings cannot rule out every rare event or guarantee safety in people with kidney disease or with use over decades. An abnormal test result must never automatically be dismissed as simply an effect of creatine. Tell the professional interpreting the results about your supplementation.
For details on markers and monitoring, see our guide to creatine, kidneys and creatinine · FR. Here, the decision criterion is simple: if there are questions about your kidney health, clarify them before starting.
Medical history, medications and tolerability
Arrange professional advice before taking any in the following situations:
- Known kidney disease, abnormal filtration or a previously reported urinary abnormality.
- Chronic illness, particularly when it involves regular medication.
- Pregnancy, breastfeeding or being under 18 years old.
- Persistent symptoms you hope to treat with the supplement.
- Taking several supplements or a blend whose ingredients are difficult to understand.
Bring all your medications, including over-the-counter products and anything taken occasionally. A pharmacist can check whether they are appropriate alongside the product you are considering. This precaution does not mean every combination is a proven interaction with creatine. Do not stop prescribed medication so you can take a supplement.
The VIDAL information sheet notes precautions concerning kidneys, pregnancy, breastfeeding and minors, as well as possible digestive problems. Its update date is old, and it does not replace more recent reviews when assessing benefits.
If you experience an unusual effect after starting, stop the supplement and seek advice. A marked decrease in urine output, unusual swelling or feeling seriously unwell calls for prompt assessment. Do not try to correct these signs by arbitrarily drinking more water or changing brands.
Decision checklist before buying
You can organise your thinking in four steps:
- Name an outcome. Strength in an exercise you track, the ability to repeat efforts or simply hoping to “function better”: that last goal needs clarifying before you buy.
- Check the population. Look for evidence matching your age, activity and health status. Exclusion from a trial limits how its results apply.
- Review the precautions. If your medical history, a symptom or a medication calls for discussion, postpone starting until that discussion has happened.
- Plan a reassessment. Note your initial goal, a comparable measurement and a review date. This is a practical organisational choice, not a validated clinical protocol. A single subjective impression does not demonstrate that the supplement works.
A loading phase is not essential: the NIH also describes regimens without loading. It resolves neither medical uncertainty nor a lack of evidence for your goal. To understand the amounts actually studied, use the guide to creatine dosing with or without loading, without copying a sports regimen to treat a cognitive complaint.
To anticipate tolerability, the guide to creatine side effects addresses a related concern. Keep the same standard of caution: no method guarantees freedom from all adverse effects.
Questions to bring to your consultation
Copy this checklist into your notes, along with a photo of the label of the product you are considering:
- Does my goal match a demonstrated benefit for someone with my profile?
- Does my medical history or do my test results change the decision?
- Do my medications and other supplements warrant any specific precautions?
- Would baseline testing or monitoring be useful in my case?
- How should I report creatine use before a blood test?
- What outcome should I track, when should I reassess, and which symptoms should prompt me to stop?
“Not starting” remains a complete decision if the expected benefit is unclear. It avoids a recurring cost and keeps attention on the problem that needs solving.
The Verdict
Main sources
This review is based on the documents below, consulted during writing. It has not undergone independent clinical review and does not constitute personalised medical advice.
